US Patent Issued to Geron on Oct. 14 for "Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms" (Massachusetts, California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,442,000, issued on Oct. 14, was assigned to Geron Corp. (Foster City, Calif.).

"Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms" was invented by Monic J. Stuart (Hillsborough, Calif.) and Stephen Kelsey (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for reducing neoplastic progenitor cell proliferation and alleviating symptoms associated in individuals diagnosed with or thought to have Essential Thrombocythemia (ET). Also provided herein are methods for using telomerase inhibitors for maintaining blood platelet counts at relatively normal ranges...